Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems

PURPOSE: The 21-gene recurrence score (RS) identifies patients with breast cancer who derive little benefit from chemotherapy; it may reduce unwarranted variability in the use of chemotherapy. We tested whether the use of RS seems to guide chemotherapy receipt across different cancer care settings....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Oncol Pract
Hauptverfasser: Afghahi, Anosheh, Mathur, Maya, Thompson, Caroline A., Mitani, Aya, Rigdon, Joseph, Desai, Manisha, Yu, Peter P., de Bruin, Monique A., Seto, Tina, Olson, Cliff, Kenkare, Pragati, Gomez, Scarlett L., Das, Amar K., Luft, Harold S., Sledge, George W., Sing, Amy P., Kurian, Allison W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2016
Schlagworte:
Original Contributions
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957259/
https://ncbi.nlm.nih.gov/pubmed/27221993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2015.009803
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge